Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Functional Studies of Novel Genes in PCD
NCT04901715Phase 1Completed
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Jun 2021
- Primary completion
- Jul 2024
- Countries
- 1
01
Overview
Phase 1, open-label trial (3 arms), sponsored by University of North Carolina at Chapel Hill. Primary endpoint: Baseline Mucociliary Clearance (Ave60Clr) at 60 minutes. Started Jun 2021; status: completed.
Beyond the preview
Go deeper on NCT04901715.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04901715.